Publications of Michael Wierer
All genres
Journal Article (26)
21.
Journal Article
12 (8), pp. 1296 - 1307 (2018)
Rapid proteomic analysis for solid tumors reveals LSD1 as a drug target in an end-stage cancer patient. Molecular Oncology 22.
Journal Article
25 (R2), pp. R106 - R114 (2016)
Proteomics to study DNA-bound and chromatin-associated gene regulatory complexes. Human Molecular Genetics 23.
Journal Article
111 (4), 51 (2016)
Stimulators of the soluble guanylyl cyclase: promising functional insights from rare coding atherosclerosis-related GUCY1A3 variants. Basic Research in Cardiology 24.
Journal Article
64 (4), pp. 645 - 658 (2016)
EPOP Functionally Links Elongin and Polycomb in Pluripotent Stem Cells. Molecular Cell 25.
Journal Article
18 (4), pp. 371 - 381 (2016)
C/EBP alpha creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4. Nature Cell Biology 26.
Journal Article
352 (6290), pp. 1221 - 1225 (2016)
ADP-ribose-derived nuclear ATP synthesis by NUDIX5 is required for chromatin remodeling. Science Meeting Abstract (1)
27.
Meeting Abstract
24 (15), p. 95 - 95. AACR Special Conference on Addressing Critical Questions in Ovarian
Cancer Research and Treatment, Pittsburgh, PA, October 01, 2017 - October 04, 2017. Association for Cancer Research, Denville, NJ (2018)
Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer. In Clinical Cancer Research,